Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-06-27

Clinical Trial Update: Efficacy of Milk Product Supplemented With Bioactives in Lowering Post Meal Glucose Response [NA]

View source ↗

Summary

Nestlé SPN completed a trial evaluating a bioactive-supplemented milk product for reducing postprandial glucose in healthy and prediabetic adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Milk product with bioactives (Nestlé)

Snippet

Sponsor: Société des Produits Nestlé (SPN) | Conditions: Healthy, PreDiabetes | NA | Status: COMPLETED